India Preclinical Research Market Overview and Insights:
According to Markntel Advisors Report, India Preclinical Research Market size was valued at around USD 175 million in 2024 and is projected to reach USD 300 million by 2030.
India Preclinical Research Market research is an ongoing process. Consistent monitoring and evaluating of market dynamics to stay informed and adapt your strategies accordingly. As a market research and consulting firm, we offer market research reports that focus on major parameters including Target Market Identification, Customer Needs and Preferences, Thorough Competitor Analysis, Market Size & Market Analysis, and other major factors. At the end, we do provide meaningful insights and actionable recommendations that inform decision-making and strategy development.
Download Report Sample PDF - https://www.marknteladvisors.com/query/request-sample/india-pre-clinical-research-market.html
Industry Growth Driver:
Regulatory Support & Policy Initiatives by the Government Augmenting Market Demand – Due to the rise in diseases in India, there is a high expenditure on preclinical research and development of drugs. It is supported by various policies and government initiatives like the Make in India, Production-Linked Incentive (PLI) Scheme, Promotion of Medical Devices Parks Scheme, etc. PLI scheme provides incentives up to USD 456 million. It is to boost the domestic research, investments, and manufacturing of medical devices such as cancer care devices, radiology and imaging devices, anesthetics devices, implants, etc. This drives the market towards growth by bringing multiple global investments into the market. Also, the Central Drugs Standard Control Organization has implemented various measures like faster timelines for approval, and an online system for submission & monitoring, to streamline the process from preclinical to clinical phases. India is aligning its regulatory framework with international guidelines like Good Laboratory Practice & Good Clinical Practice which is important to ensure data credibility in preclinical research encouraging global acceptance and investment in the Indian market. For Instance;
What is Included in India Preclinical Research Market Segmentation?
The report has segmented the market into the following categories:
By Model Type
- Patient-Derived Organoid (PDO) model- Market Size & Forecast 2020-2030, USD Million
- Patient-Derived Xenograft (PDX) model- Market Size & Forecast 2020-2030, USD Million
Out of them, the Patient-Derived Organoid (PDO) Model leads the market with more than 50% of the market share. PDO models are becoming increasingly crucial in preclinical research as they provide a closer stimulation of human biology than animal models. This allows more accurate preclinical testing and helps in creating drugs for highly complex diseases like cancer. In India, they find their major application in personalized medicine as they work on patient-specific tissues for testing drug efficacy, ultimately helping in tailored healthcare. With multiple investments and the provision of resources in the Indian market by pharmaceutical and biotechnology companies in advanced preclinical models like PDOs, there is a high improvement in the predictability of drug outcomes and streamlined clinical trial processes. For Instance;
By Service
- Bioanalysis and DMPK studies- Market Size & Forecast 2020-2030, USD Million
- - In vitro ADME- Market Size & Forecast 2020-2030, USD Million
- - In-vivo PK- Market Size & Forecast 2020-2030, USD Million
- Toxicology testing- Market Size & Forecast 2020-2030, USD Million
- - GLP- Market Size & Forecast 2020-2030, USD Million
- - Non-GLP- Market Size & Forecast 2020-2030, USD Million
- Compound management- Market Size & Forecast 2020-2030, USD Million
- - Process R&D- Market Size & Forecast 2020-2030, USD Million
- - Custom synthesis- Market Size & Forecast 2020-2030, USD Million
- - Others- Market Size & Forecast 2020-2030, USD Million
- Chemistry- Market Size & Forecast 2020-2030, USD Million
- - Medicinal chemistry- Market Size & Forecast 2020-2030, USD Million
- - Computation chemistry- Market Size & Forecast 2020-2030, USD Million
- Safety Pharmacology-Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
By End User
- Biopharmaceutical Companies- Market Size & Forecast 2020-2030, USD Million
- Government and academic institutes- Market Size & Forecast 2020-2030, USD Million
- Medical device companies- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
By Region
- North
- East
- West
- South
Access the Complete Report for An In-Depth Analysis - https://www.marknteladvisors.com/research-library/india-pre-clinical-research-market.html
Who are the Key Players Operating in the India Preclinical Research Industry?
The top companies of the India Preclinical Research market ruling the industry are:
- Syngene International Limited
- Dabur Research
- JSS Medical Research
- Jubilant Biosys Ltd.
- Sugen Life Sciences
- Eurofins Advinus
- GVRP
- Veeda Clinical Research Limited
- Axis Clinicals
- Syneos Health
- Ethicare-cro
- Liveon Biolabs Pvt. Ltd.
- IQVIA Inc.
- Bioneeds
- TheraIndx Lifesciences Pvt. Ltd.
- Abiogenesis Clinpharm
- Accutest Global
- Asiatic Clinical Research
- Bio Reliance Corporation
- Cliniminds
- Hi Tech Bio Laboratories
- GVK Biosciences
Customize This Report to Fit Your Requirement, We're offering discounts on Purchase of the Report, Get It Today - https://www.marknteladvisors.com/query/request-customization/india-pre-clinical-research-market.html
("Kindly use your official email ID for all correspondence to ensure seamless engagement and access to exclusive benefits, along with prioritized support from our sales team.")
Key Objectives of Choosing Markntel Advisor’s Report
- Focused Industry Expertise
- Diverse Report Offerings
- Personalized Research Solutions
- Robust Research Methodology
- In-depth Report Coverage
- Tracking Technological Advancements
- Comprehensive Value-Chain Analysis
- Discovering Market Opportunities
- Analyzing Growth Trajectories
- Assured Quality Insights
- Dedicated After-Sales Support
- Trusted by Fortune 500 Companies
*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address
FAQs (Frequently Ask Questions)
- What are the industry’s overall statistics or estimates including CARG and USD Value of the forecasting years?
- What are the trends influencing the current scenario of the India Preclinical Research Market?
- What are the key factors that would propel and hinder the industry?
- Which geographical area dominates the India Preclinical Research industry?
- Which is the Leading segment in the market?
About US:
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
For Media Inquiries, Please Contact:
Phone: +1 628 895 8081 | +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
